Drug Trial Radar · NCT07871097
Acute Treatment of Vestibular Migraine by Rimegepant
Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Dec 1, 2025
Primary completion
Nov 30, 2027
Study completion Dec 1, 2027
Sponsor
- Lead sponsor
- Wensheng QuAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Wuhan No.1 Hospital; Wuhan Puren Hospital; Xiangyang Central Hospital; Xinyang Central Hospital
- First posted
- Oct 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate whether rimegepant improves acute vestibular symptoms and accompanying discomforts in patients with vestibular migraine.
Conditions
- Vestibular Migraine
Interventions
First dose rimegepant, second dose placeboDrug
First dose rimegepant, second dose placebo
First dose placebo, second dose rimegepantDrug
First dose placebo, second dose rimegepant
Primary outcomes
What the sponsor says the trial is designed to measure.
- Vertigo symptom relief rateTime frame: 2 hours after medication
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tongji Hospital
Wuhan, Hubei, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.